Pacira Pharmaceuticals buy Needham & Company LLC
Start price
28.02.23
/
50%
€40.40
Target price
28.02.24
€56.63
Performance (%)
-32.18%
End price
29.02.24
€27.40
Summary
This prediction ended on 29.02.24 with a price of €27.40. The BUY prediction by Needham___Company_LL for Pacira Pharmaceuticals performed very badly with a performance of -32.18%. Needham___Company_LL has a follow-up prediction for Pacira Pharmaceuticals where he still thinks Pacira Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.167% | 4.167% | -39.614% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Needham___Company_LL for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Needham & Company LLC from $63.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€33.40
03.08.23
03.08.23
€47.53
03.08.24
03.08.24
-25.15%
02.05.24
02.05.24
Stopped prediction by Needham___Company_LL for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€25.80
09.04.24
09.04.24
€41.35
09.04.25
09.04.25
-3.10%
02.05.24
02.05.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
01.03.24
01.03.24
€41.61
01.03.25
01.03.25
-6.72%
02.05.24
02.05.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
20.04.23
20.04.23
€54.71
20.04.24
20.04.24
-40.98%
21.04.24
21.04.24